Overview: Kidney Biopsy Electron Microscopy TestIntroduction: The Kidney Biopsy Electron Microscopy Test provides slides/images to diagnose kidney disorders, causing swelling or blood in urine. Following 2023 ASN guidelines, it uses electron microscopy for high specificity, supporting renal screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in histopathology for patients with suspected kidney disorders.
Other Names: Kidney Biopsy Slides, Renal EM Test.
FDA Status: Laboratory-developed test (LDT), meeting histopathology standards for diagnostic accuracy.
Historical Milestone: Kidney biopsy electron microscopy began in the 1960s with nephrology research. Imaging techniques improved in the 2000s, enhancing diagnostic precision.
Purpose: Provides slides/images for kidney biopsy to diagnose kidney disorders, guides treatment, and evaluates patients with swelling or blood in urine.
Test Parameters: 1. Electron Microscopy Slides
Pretest Condition: No fasting required. Collect tissue or slides. Report history of swelling, hematuria, or renal dysfunction.
Specimen: Tissue (sterile container, 0.5-2 cma³), Slide (1-2 slides). Transport in a biohazard container.
Sample Stability at Room Temperature: Indefinite
Sample Stability at Refrigeration: Not refrigerated
Sample Stability at Frozen: Not frozen
Medical History: Document swelling, hematuria, proteinuria, or family history of kidney disease. Include current medications, especially immunosuppressants.
Consent: Written consent required, detailing the tests purpose, kidney disorder implications, and risks of biopsy.
Procedural Considerations: Uses electron microscopy to analyze kidney tissue or slides. Results are available in 5-7 days, supporting clinical decisions. Performed in laboratories, often for kidney disorder diagnosis.
Factors Affecting Result Accuracy: Improper tissue fixation or processing can affect results. Low tissue quality may reduce imaging clarity.
Clinical Significance: Abnormal electron microscopy findings confirm kidney disorders (e.g., glomerulonephritis), guiding therapy. Normal findings may require further testing.
Specialist Consultation: Consult a nephrologist for result interpretation and treatment planning.
Additional Supporting Tests: Light microscopy, immunofluorescence, or renal ultrasound to confirm kidney disorder diagnosis.
Test Limitations: Not specific to one kidney disorder; clinical correlation is needed. Invasive biopsy carries risks.
References: ASN Nephrology Guidelines, 2023; Kidney International, D'Agati VD, 2022.
